文献速递腹部MR

增殖型肝细胞癌的钆塞酸增强MRI特征及术后预后意义

Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
PubMed 文献 · Radiology · 2021-07-06

该回顾性队列研究纳入158例手术切除的单发≤5cm初治HCC患者,术前接受钆塞酸增强MRI。26.6%为增殖型HCC,其与更差总生存、更高肝内远处复发和肝外转移相关。MRI环状动脉期高强化和高AFP是增殖型HCC的独立预测因子,环状APHE还与不良OS和肝外转移相关。

要点

  • 钆塞酸增强MRI上环状动脉期高强化提示增殖型HCC可能,与不良预后相关。
  • 增殖型HCC术后总生存更差,肝内远处复发和肝外转移风险更高。
  • 血清AFP>100 ng/mL也是增殖型HCC的独立预测因子。

临床应用与阅片要点

  • 阅片时注意动脉期环状高强化征象,提示增殖型HCC可能。
  • 对具有环状APHE的HCC患者,报告可提示预后不良及肝外转移风险。
  • 结合血清AFP水平(>100 ng/mL)综合评估增殖型HCC风险。

局限性

  • 回顾性单中心研究,样本量有限(158例)。
  • 增殖型HCC各亚型样本量小,亚组分析受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Hepatocellular carcinomas (HCCs) are heterogeneous neoplasms, and the prognosis varies based on the subtype. Two broad molecular classes of HCC have been proposed: a proliferative and a nonproliferative class. Purpose To evaluate the gadoxetate-enhanced MRI findings of the proliferative class HCC and its prognostic significance after surgery. Materials and Methods This retrospective cohort study evaluated patients with surgically resected treatment-naive single HCC (≤5 cm) who underwent hepatic resection from January 2010 through February 2013 and preoperative gadoxetate-enhanced MRI. A Cox proportional hazards model was used to determine the predictive factors for overall survival (OS), intrahepatic distant recurrence, and extrahepatic metastasis (EM). The mean follow-up period was 75.5 months ± 30.2 (standard deviation). Multivariable logistic regression was performed to determine factors associated with proliferative class HCC. Results A total of 158 patients (mean age, 57 years ± 11; 128 men and 30 women) were evaluated. Forty-two of the 158 HCCs (26.6%) were proliferative class HCCs (17 macrotrabecular-massive HCCs, 14 keratin 19-positive HCCs, 10 scirrhous HCCs, and one sarcomatoid HCC). The proliferative class was associated with worse OS (hazard ratio [HR], 3.1; 95% CI: 1.5, 6.0; P = .01) and higher rates of intrahepatic distant recurrence (HR, 1.83; 95% CI: 1.1, 2.9; P = .01) and EM (HR, 9.97; 95% CI: 3.2, 31.4; P < .001). Rim arterial phase hyperenhancement (APHE) at gadoxetate-enhanced MRI (odds ratio [OR], 6.35; 95% CI: 1.9, 21.7; P = .01) and high serum α-fetoprotein (>100 ng/mL) (OR, 4.18; 95% CI: 1.64, 10.7; P = .01) were independent predictors for proliferative HCC. The presence of rim APHE was associated with poor OS (HR, 2.4; 95% CI: 1.2, 4.9; P = .02) and higher rates of EM (HR, 7.4; 95% CI: 2.5, 21.7; P < .01). Conclusion The proliferative class of hepatocellular carcinoma (HCC) is an independent factor for poor overall survival with increased rates of intrahepatic and extrahepatic metastasis. Rim arterial phase hyperenhancement at gadoxetate-enhanced MRI may help to identify proliferative class HCC and predict poor overall survival and an increased incidence of extrahepatic metastasis. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Krinsky and Shanbhogue in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kang HJ, Kim H, Lee DH, et al. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery. Radiology. 2021. PMID: 34227881. doi:10.1148/radiol.2021204352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。